Ayden Haselhorst, age 17, South Dakota

Ayden Haselhorst’s journey with type 1 diabetes (T1D) began a decade before his diagnosis, when he was first screened by TrialNet for autoantibodies that signal increased risk.

A new clinical study is testing rezpegaldesleukin to see if it can help people recently diagnosed with type 1 diabetes continue to make insulin by resetting the body's natural immune balance. Rezpegaldesleukin has already shown promising results in clinical trials for other autoimmune diseases, including atopic dermatitis and lupus.

After successfully giving birth to her first child in 2010, Brooke Gibson was shocked when her fertility specialist told her that she would most likely not be able to have a second biological child due to her type 1 diabetes (T1D). Confident that this information was wrong, she sought a second opinion from another fertility specialist, and together they developed a plan.